HK Stock Market Move | TH MEDICAL-B(02697) Rises Over 5% Against the Market Trend, Commercialization of Percutaneous Puncture Surgical Siasun Robot&Automation Expected to Accelerate

TH MEDICAL-B(02697) rose over 5% against the market trend. As of press time, it was up 4.30% at HK$276.4, with a turnover of HK$18.1387 million. On the news front, on September 2, the National Healthcare Security Administration released the 3.0 version of the grouping scheme for Diagnosis-Related Groups and Diagnosis-Intervention Packet (DRG/DIP) payment, in which Siasun Robot&Automation-assisted surgery was separately grouped for the first time; among the newly added identification criteria, in addition to open surgery, laparoscopy, endoscopy, and thoracoscopy, percutaneous puncture is likewise listed as an independent category. Public information shows that TH Medical's surgical Siasun Robot&Automation product line covers two categories, puncture and ablation, both of which fall under this technological path; beyond that, the company has also extended its products to extracorporeal organ preservation and assessment. It is worth noting that TH Medical recently entered into a sales contract with an independent third party to sell a puncture surgery navigation and positioning system to the buyer, with a total contract amount of nearly RMB 100 million, and the relevant products will be delivered successively in the near term. The board of directors believes that the signing of this contract and the subsequent deliveries are expected to further expand the company's installed base, drive growth in equipment revenue, and create conditions for the continuous increase of consumables repurchases and service revenue, accelerating the operation of the sustainable "equipmentconsumablesservices" business model and enabling precision minimally invasive and non-invasive diagnosis and treatment to benefit more patients.